Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

This study has been terminated.

( Study was terminated due to lack of enrollment and businesss decisions. )

Study NCT00597909 Information provided by Hyperion Therapeutics, Inc.

First Received: January 9, 2008 Last Updated: July 14, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Hepatic Encephalopathy

Additional conditions recognized in this trial

Brain Damage, Chronic
Delirium
Encephalitis
Neurotoxicity Syndromes

Interventions listed in this trial

placebo solution (10% dextrose)

Additional drug interventions recognized in this trial

Benzoates
Phenylacetic acid
Sodium Benzoate

More general drug interventions related to this trial

Anti-Infective Agents
Antifungal Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses

Sponsors listed in this trial

Hyperion Therapeutics, Inc.

Back to top of Main Content